The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Boston Scientific continues to deliver robust growth, but valuation limits upside despite strong execution and leading positions in key medical device markets. BSX's growth drivers—Farapulse (PFA), ...

Boston Scientific is recommended as a buy with a $109 target price, implying 14% upside, driven by robust demand and niche leadership. BSX outpaces market growth through focused M&A, strong execution ...

Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12, TD Cowen reaffirmed a Buy rating on Boston Scientific Corporation (NYSE:BSX) and kept a ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ...

One late afternoon in mid-October, Taylor McNeilly, a 36-year-old archivist teaching at Simmons University, set off to campus from their family home in Glocester, R.I., about five minutes later than ...

An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...

The Clicks Communicator looks like a BlackBerry phone, but it's designed as a companion device to your smartphone to help you focus. Julian is a contributor and former staff writer at CNET. He's ...